Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

190
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
190
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.3K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.3K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

329
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
329

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Representation of women in surgery in Pakistan: Analysis of trends.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

Colorectal Cancer: Correlating the Role of Peritoneal Fluid Cytology to Tumor Biology and Stage: A Prospective Study from Pakistan.

Euroasian journal of hepato-gastroenterology·2026
Same author

Exploring effects of severe mental illnesses on marriages: A qualitative study from Karachi, Pakistan.

PLOS global public health·2025
Same author

Exploring Body Image Satisfaction in Post-Mastectomy Female Breast Cancer Patients.

European journal of breast health·2025
Same author

Impact of the Laparoscopic Approach on Liver Function Tests: Comparison of Elective Biliary and Non-biliary Procedures.

Cureus·2025
Same author

Daughters and daughters-in-law providing elderly care: a qualitative study from Karachi, Pakistan.

BMC geriatrics·2024

Related Experiment Video

Updated: Feb 24, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.8K

Biobanking in the subcontinent: exploring concerns.

Aamir M Jafarey1, Sualeha Siddiq Shekhani2, Bushra Shirazi3

  • 1Professor, Centre of Biomedical Ethics and Culture, Sindh Institute of Urology and Transplantation, Karachi, Pakistan,. aamirjafarey@gmail.com.

Indian Journal of Medical Ethics
|August 14, 2017
PubMed
Summary
This summary is machine-generated.

Biobanking presents ethical challenges, especially in developing nations. Clarity on biobank definitions and informed consent for indefinite sample storage is needed, alongside addressing cross-border transfer concerns.

More Related Videos

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
06:42

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Published on: September 2, 2025

646
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.9K

Related Experiment Videos

Last Updated: Feb 24, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.8K
Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
06:42

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Published on: September 2, 2025

646
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.9K

Area of Science:

  • Biomedical Research Ethics
  • Biobanking
  • Global Health

Background:

  • Biobanking is crucial for biomedical research but poses significant ethical dilemmas.
  • These ethical issues are often amplified in developing countries.
  • Existing frameworks may not adequately address the complexities of biobanking in diverse global contexts.

Purpose of the Study:

  • To explore the ethical issues associated with biobanking in developing regions.
  • To identify ambiguities and areas needing further discourse in biobanking ethics.
  • To understand perspectives on informed consent, sample storage, and cross-border transfer.

Main Methods:

  • A mixed-method pilot study involving students in Karachi, Pakistan.
  • Two workshops were conducted: one in Karachi and another in Bengaluru, India.
  • Data collection involved surveys and discussions to gather diverse viewpoints.

Main Results:

  • A consistent lack of clarity regarding the definition of a biobank was observed.
  • Participants emphasized the necessity of informed consent but expressed uncertainty about its application for indefinite future research.
  • Concerns regarding the potential misuse of biospecimens, particularly during cross-border transfers, were raised.

Conclusions:

  • There are significant ambiguities in understanding and addressing the ethical challenges of biobanking.
  • Further dialogue and development of ethical guidelines are essential for responsible biobanking practices.
  • Addressing the specific needs and contexts of developing countries is critical for global biobanking initiatives.